| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.008 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |